[go: up one dir, main page]

NO984759D0 - Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi - Google Patents

Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi

Info

Publication number
NO984759D0
NO984759D0 NO984759A NO984759A NO984759D0 NO 984759 D0 NO984759 D0 NO 984759D0 NO 984759 A NO984759 A NO 984759A NO 984759 A NO984759 A NO 984759A NO 984759 D0 NO984759 D0 NO 984759D0
Authority
NO
Norway
Prior art keywords
osmolyte
ischemia
medicament
manufacture
treatment
Prior art date
Application number
NO984759A
Other languages
English (en)
Other versions
NO984759L (no
Inventor
Dieter Houssinger
Original Assignee
Dieter Houssinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Houssinger filed Critical Dieter Houssinger
Publication of NO984759D0 publication Critical patent/NO984759D0/no
Publication of NO984759L publication Critical patent/NO984759L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO984759A 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi NO984759L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601396A SE9601396D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 2
PCT/EP1997/001861 WO1997038685A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia

Publications (2)

Publication Number Publication Date
NO984759D0 true NO984759D0 (no) 1998-10-12
NO984759L NO984759L (no) 1998-10-12

Family

ID=20402175

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984759A NO984759L (no) 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi

Country Status (7)

Country Link
EP (1) EP0946167A1 (no)
JP (1) JP2000508651A (no)
AU (1) AU2386097A (no)
CA (1) CA2251071A1 (no)
NO (1) NO984759L (no)
SE (1) SE9601396D0 (no)
WO (1) WO1997038685A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
ATE247981T1 (de) 1999-06-12 2003-09-15 Bitop Ag Proteinenthaltende pharmazeutische zubereitung
EP1272201B1 (de) * 2000-04-12 2004-11-24 Bitop Aktiengesellschaft Für Biotechnische Optimierung Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
JP5084089B2 (ja) * 2001-06-14 2012-11-28 大塚製薬株式会社 医薬組成物
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
DE10330768A1 (de) * 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
RU2259822C1 (ru) * 2004-02-27 2005-09-10 ЗАО "НПО ПЦ Биофизика" Противоишемическое средство, обладающее противоаритмическим и противоатерогенным действием, и способ его применения
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
DE102008006780A1 (de) * 2008-01-30 2009-08-06 Bitop Ag Verwendung von Tetrahydropyrimidinen
JP2021147393A (ja) * 2020-03-13 2021-09-27 ロート製薬株式会社 酸化ストレス抑制剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JP2642198B2 (ja) * 1989-08-24 1997-08-20 元庸 村上 胃粘膜障害治療剤
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
AU7584891A (en) * 1990-03-19 1991-10-21 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5312839A (en) * 1991-03-05 1994-05-17 Regents Of The University Of California Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis
CH686870A5 (fr) * 1992-09-18 1996-07-31 Pasteur Merieux Serums Vacc Solution de perfusion, de conservation et de reperfusion d'organes.
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates

Also Published As

Publication number Publication date
EP0946167A1 (en) 1999-10-06
WO1997038685A1 (en) 1997-10-23
JP2000508651A (ja) 2000-07-11
AU2386097A (en) 1997-11-07
NO984759L (no) 1998-10-12
SE9601396D0 (sv) 1996-04-12
CA2251071A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
FI973868L (fi) D2-vitamiini- tai D4-vitamiinijohdannaisten käyttö sekundaarisen hyperparatyreoosin hoitoon tarkoitettu lääkkeen valmistuksessa
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
HUP9800034A3 (en) Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
TR199501560A2 (tr) Kademeli olarak saliverilen kafein formülasyonu.
FI956014L (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
DK0769017T3 (da) Terapeutiske forbindelser
NO984759D0 (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
GB2319729B (en) A film for topical use in the treatment of wounds
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
GB9726343D0 (en) The use of excipients to accelerate freeze-drying
NO991158L (no) FremgangsmÕte for behandling av amyotrofisk lateralsklerose
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application